Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LINC01128 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IGK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHRNB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FEZF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NARR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF220 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZMYM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGEB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01398 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCAF15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMARCD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POSTN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EXOSC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRAMP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00472 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELF5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on